Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Treasury Shares (2023 - 2025)

Historic Treasury Shares for InMed Pharmaceuticals (INM) over the last 3 years, with Q4 2025 value amounting to $3.7 million.

  • InMed Pharmaceuticals' Treasury Shares rose 782608.53% to $3.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $3.7 million, marking a year-over-year increase of 782608.53%. This contributed to the annual value of $4.5 million for FY2025, which is 73435.18% up from last year.
  • As of Q4 2025, InMed Pharmaceuticals' Treasury Shares stood at $3.7 million, which was up 782608.53% from $3.9 million recorded in Q3 2025.
  • In the past 5 years, InMed Pharmaceuticals' Treasury Shares ranged from a high of $13.2 million in Q1 2024 and a low of $42096.0 during Q1 2025
  • In the last 3 years, InMed Pharmaceuticals' Treasury Shares had a median value of $551773.5 in 2023 and averaged $2.7 million.
  • Within the past 5 years, the most significant YoY rise in InMed Pharmaceuticals' Treasury Shares was 782608.53% (2025), while the steepest drop was 9968.12% (2025).
  • Over the past 3 years, InMed Pharmaceuticals' Treasury Shares (Quarter) stood at $559267.0 in 2023, then tumbled by 91.56% to $47176.0 in 2024, then skyrocketed by 7826.09% to $3.7 million in 2025.
  • Its Treasury Shares stands at $3.7 million for Q4 2025, versus $3.9 million for Q3 2025 and $4.5 million for Q2 2025.